• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

XLHealth optimistic about special needs plans

Article

XLHealth, a Baltimore-based provider of health plan solutions for Medicare beneficiaries with special needs, announced the enrollment of its 100,000th member, and it sees room for more growth despite expected Medicare Advantage cuts

XLHealth, a Baltimore-based provider of health plan solutions for Medicare beneficiaries with special needs, announced the enrollment of its 100,000th member, and it sees room for more growth despite expected Medicare Advantage cuts.

“There is going to be increasing downward price cut pressure on all plans,” says Paul Serini, executive vice president, XLHealth. “As a starting point we’ll have that same pressure. That said, most of healthcare reform is aligned with special need plans like ours.”

He says in the next two to four years, he sees tremendous opportunities for special needs plans.

“When the dust settles from healthcare reform, any MAPD (Medicare Advantage Prescription Drug) company serving a population that’s complex enough can do a better job than traditional services,” he says. “We know we can deliver better value to our members and the Medicare system for the chronically ill.”

XLHealth focuses on a largely rural, medically underserved market and targets older members. Care Improvement Plus' chronic condition special needs plan combines medical coverage - hospital and doctors' visits - with tailored Medicare Part D prescription drug coverage and care management support for Medicare beneficiaries with diabetes and heart failure.

Care Improvement Plus launched in 2006 and now serves seniors in Arkansas, Georgia, Missouri, South Carolina, Texas and 11 Maryland counties.  XLHealth estimates that approximately 7 million Medicare beneficiaries across all six states are eligible to enroll in a Care Improvement Plus plan and benefit from its model of care.

Serini says the company plans to expand in 2012. It has a target list of seven more states and 170 counties.

Related Videos
Video 8 - "Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization"
Video 7 - "Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider"
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
Video 6 - "Failing to Reach Ideal Diabetes Care: Equitable Doesn’t Mean Equal"
Video 5 - "Revising Diabetes Outcome Measures"
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Related Content
© 2024 MJH Life Sciences

All rights reserved.